ES2728199T3 - Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP) - Google Patents

Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP) Download PDF

Info

Publication number
ES2728199T3
ES2728199T3 ES14176452T ES14176452T ES2728199T3 ES 2728199 T3 ES2728199 T3 ES 2728199T3 ES 14176452 T ES14176452 T ES 14176452T ES 14176452 T ES14176452 T ES 14176452T ES 2728199 T3 ES2728199 T3 ES 2728199T3
Authority
ES
Spain
Prior art keywords
inhibitors
agents
combination
aminin
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14176452T
Other languages
English (en)
Spanish (es)
Inventor
Ontoria Jesus Maria Ontoria
Rita Scarpeli
Carsten Schultz-Fademrecht
Philip Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD Italia SRL
Original Assignee
MSD Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2728199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by MSD Italia SRL filed Critical MSD Italia SRL
Application granted granted Critical
Publication of ES2728199T3 publication Critical patent/ES2728199T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES14176452T 2007-01-10 2008-01-08 Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP) Active ES2728199T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0700432.8A GB0700432D0 (en) 2007-01-10 2007-01-10 Therapeutic compounds
US92131007P 2007-04-02 2007-04-02

Publications (1)

Publication Number Publication Date
ES2728199T3 true ES2728199T3 (es) 2019-10-22

Family

ID=37809722

Family Applications (3)

Application Number Title Priority Date Filing Date
ES14176452T Active ES2728199T3 (es) 2007-01-10 2008-01-08 Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP)
ES11157369.7T Active ES2509115T3 (es) 2007-01-10 2008-01-08 Combinaciones que contienen indazoles sustituidos con amida como inhibidores de poli(ADP-ribosa) polimerasa (PARP)
ES08702101T Active ES2362214T3 (es) 2007-01-10 2008-01-08 Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES11157369.7T Active ES2509115T3 (es) 2007-01-10 2008-01-08 Combinaciones que contienen indazoles sustituidos con amida como inhibidores de poli(ADP-ribosa) polimerasa (PARP)
ES08702101T Active ES2362214T3 (es) 2007-01-10 2008-01-08 Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).

Country Status (21)

Country Link
CN (1) CN101578279B (fr)
AT (1) ATE502933T1 (fr)
CR (1) CR10910A (fr)
DE (1) DE602008005711D1 (fr)
DK (2) DK2109608T3 (fr)
ES (3) ES2728199T3 (fr)
GB (1) GB0700432D0 (fr)
HN (1) HN2009001260A (fr)
HU (1) HUE044513T2 (fr)
LT (1) LT2805945T (fr)
LU (1) LUC00072I2 (fr)
ME (1) ME03481B (fr)
MY (1) MY147789A (fr)
NI (1) NI200900135A (fr)
NZ (1) NZ578256A (fr)
PE (1) PE20081558A1 (fr)
PT (3) PT2336120E (fr)
SI (2) SI2336120T1 (fr)
TW (1) TWI528961B (fr)
UA (1) UA97658C2 (fr)
ZA (1) ZA200903898B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106496187A (zh) * 2016-09-14 2017-03-15 陕西科技大学 一种制备PARP抑制剂Niraparib的合成方法
CN106432187A (zh) * 2016-09-17 2017-02-22 青岛云天生物技术有限公司 2‑[4‑(‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的手性拆分方法
CN106432188A (zh) * 2016-09-17 2017-02-22 青岛辰达生物科技有限公司 一种抗癌药2‑[4‑((3s)‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的制备方法
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
CN106632244A (zh) * 2016-09-30 2017-05-10 陕西科技大学 一种制备抗癌药物Niraparib的新型合成方法
CN108201537A (zh) * 2016-12-16 2018-06-26 苏州苏融生物医药有限公司 一种尼拉帕尼缓控释药物组合物及其用途
KR20190130625A (ko) * 2017-03-27 2019-11-22 테사로, 인코포레이티드 니라파립 제제
CN109081828B (zh) * 2017-06-14 2021-03-26 上海时莱生物技术有限公司 聚(adp-核糖)聚合酶抑制剂、制备方法及用途
TWI843707B (zh) 2017-09-26 2024-06-01 美商提薩羅有限公司 尼拉帕尼(niraparib)調配物
CN108084157A (zh) * 2018-02-12 2018-05-29 安庆奇创药业有限公司 一种尼拉帕尼的合成方法
CN108203404A (zh) * 2018-03-02 2018-06-26 上海博邦医药科技有限公司 (r)-3-苯基哌啶或/和(s)-3-苯基哌啶以及尼拉帕尼的手性中间体的合成方法
CA3169303A1 (fr) 2020-02-24 2021-09-02 Xiaokun SHEN Application anti-coronavirus de l'inhibiteur de la poly adp-ribose polymerase
CN115611860B (zh) * 2021-07-13 2024-06-11 上海博璞诺科技发展有限公司 合成尼拉帕尼的方法

Also Published As

Publication number Publication date
LT2805945T (lt) 2019-06-25
TWI528961B (zh) 2016-04-11
GB0700432D0 (en) 2007-02-21
ES2362214T3 (es) 2011-06-29
CN101578279B (zh) 2013-07-17
PT2109608E (pt) 2011-05-30
HN2009001260A (es) 2012-03-26
PE20081558A1 (es) 2008-10-30
NZ578256A (en) 2011-12-22
DE602008005711D1 (de) 2011-05-05
MY147789A (en) 2013-01-31
LUC00072I2 (fr) 2018-07-04
CR10910A (es) 2010-01-19
DK2109608T3 (da) 2011-07-11
PT2805945T (pt) 2019-06-06
SI2336120T1 (sl) 2014-10-30
ES2509115T3 (es) 2014-10-17
ATE502933T1 (de) 2011-04-15
HUE044513T2 (hu) 2019-10-28
ME03481B (fr) 2020-01-20
UA97658C2 (ru) 2012-03-12
SI2109608T1 (sl) 2011-07-29
NI200900135A (es) 2010-08-30
PT2336120E (pt) 2014-10-01
ZA200903898B (en) 2010-04-28
CN101578279A (zh) 2009-11-11
TW200836731A (en) 2008-09-16
DK2336120T3 (da) 2014-10-06

Similar Documents

Publication Publication Date Title
ES2728199T3 (es) Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP)
ES2548131T3 (es) Sales farmacéuticamente aceptables de 2-{4-[(3S)-piperidin-3-il]fenil}-2H-indazol-7-carboxamida
EP2805945B1 (fr) Indazoles substitués d'amide en tant qu'inhibiteurs PARP de poly(ADP-ribose)polymérase
ES2524787T3 (es) Derivados de piridazinona como inhibidores de PARP
HK40006670A (en) Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
HK1154386B (en) Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
HK1131137B (en) Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors